Crop Life Science Share Price & Earnings Call Analysis
₹93.00+4.73% today
- Market cap
- ₹159 Cr
- P/E
- 23.06
- ROE
- 8.45%
- PEG
- 1.20
- Price to sales
- 0.79
- Debt to equity
- 0.66
- Sales growth (5Y)
- 13.71%
- EBITDA margin
- 8.38%
- Net profit margin
- 3.41%
- Promoter holding
- 67.21%
- Sales (last year)
- ₹203 Cr
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Crop Life Scienc
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Crop Life Scienc
Quarterly Results
Quarter-by-quarter operating performance
No quarterly results data available for this company yet.
Financials of Crop Life Scienc
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 126 | 107 | 94 | 130 | 191 | 196 | 207 |
| Expenses + | 118 | 98 | 86 | 118 | 178 | 180 | 190 |
| Operating Profit | 8 | 9 | 8 | 12 | 13 | 16 | 17 |
| OPM % | 7% | 8% | 8% | 9% | 7% | 8% | 8% |
| Other Income + | 0 | 1 | 0 | 1 | 2 | 1 | 2 |
| Interest | 2 | 2 | 2 | 3 | 3 | 5 | 5 |
| Depreciation | 2 | 3 | 2 | 4 | 3 | 3 | 3 |
| Profit before tax | 5 | 5 | 4 | 6 | 8 | 9 | 10 |
| Tax % | 30% | 25% | 25% | 27% | 26% | 26% | 29% |
| Net Profit + | 3 | 4 | 3 | 4 | 6 | 7 | 7 |
| EPS in Rs | 2.69 | 3.08 | 2.34 | 3.39 | 3.52 | 3.86 | 4.08 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Crop Life Scienc
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 17 | 17 | 17 |
| Reserves | 18 | 21 | 24 | 29 | 55 | 61 | 68 |
| Borrowings + | 16 | 18 | 22 | 27 | 34 | 44 | 57 |
| Other Liabilities + | 31 | 35 | 37 | 34 | 67 | 55 | 63 |
| Total Liabilities | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
| Fixed Assets + | 12 | 13 | 11 | 16 | 22 | 22 | 16 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 12 | 13 | 13 |
| Other Assets + | 64 | 73 | 82 | 86 | 138 | 142 | 177 |
| Total Assets | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
Financials of Crop Life Scienc
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 3 | 4 | -0 | 2 | -8 | -2 | |
| Cash from Investing Activity + | -1 | -2 | -2 | -4 | -16 | -3 | |
| Cash from Financing Activity + | -3 | -1 | 1 | 1 | 24 | 6 | |
| Net Cash Flow | -1 | 1 | -1 | -2 | 0 | 0 | |
| Free Cash Flow | 2 | 1 | -2 | -3 | -13 | -6 | |
| CFO/OP | 46% | 58% | 11% | 34% | -49% | -1% |
Financials of Crop Life Scienc
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 89 | 143 | 92 | 148 | 129 | 131 |
| Inventory Days | 93 | 159 | 137 | 104 | 99 | 126 | 170 |
| Days Payable | 72 | 108 | 137 | 79 | 131 | 107 | 127 |
| Cash Conversion Cycle | 100 | 140 | 143 | 116 | 117 | 148 | 174 |
| Working Capital Days | 50 | 74 | 93 | 86 | 86 | 89 | 103 |
| ROCE % | 14% | 11% | 14% | 13% | 12% | 12% |